Avadel Pharmaceuticals plc was registered as an Irish private limited company on December 1, 2015 and re-registered as an Irish public limited company on November 21, 2016. Avadel Pharmaceuticals plc is a specialty pharmaceutical company with a long history in drug delivery, focusing on developing safer and more effective formulations that address unmet pharmaceutical needs during research. The company focuses on: (1) the development and licensing of five functional and proprietary drug delivery platforms, (2) the development of novel, high-value products based on drug delivery platforms, and (3) the development, approval and marketing of niche brand and generic products in the United States after the acquisition of Eclat Pharmaceuticals. 

AVDL(Delisted)